CELESIA, ADRIANA
CELESIA, ADRIANA
Dipartimento di Scienze Farmaceutiche
Onconase Induces Apoptosis in Dabrafenib-Resistant Melanoma Cell Lines Through Dysregulation of ROS Homeostasis, Antioxidant Protein Expression, and Mitochondrial Dynamics
2026 C. Passarini, A. Cardile, F. Zuanetti, V. Zanrè, R. Pacchiana, A. Celesia, F. Danzi, A. Fiore, G. Gotte, M. Menegazzi
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
2026 M. Poles, R. Pacchiana, C. Mortali, B. Cisterna, N. Mullappilly, A. Celesia, F. Danzi, M. Gaspari, D. Cecconi, M. Donadelli, A. Fiore
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells
2025 F. Danzi, G. Butera, D. Sutton, M.D. Perricone, Y. Hu, A. Celesia, M. Manfredi, J. Brandi, N. Pourmandi, N.S. Nelson, L. Lin, M. Bevere, R. Pacchiana, A. Pea, R. Salvia, A. Scarpa, C. Luchini, D. Cecconi, S. Ugel, C.A. Lyssiotis, A. Fiore, M. Donadelli
Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation
2025 L. Dalle Carbonare, A. Minoia, S. Zouari, M. Braggio, M. Cominacini, S.C. Gaglio, F.C. Piritore, P. Lorenzi, M. Meneghel, K. Dervishi, A. Corsi, A. Pedrinolla, G. Giuriato, A. Fiore, A. Celesia, L. Guerricchio, M. Venturelli, F. Schena, M. Donadelli, M. Mottes, M.G. Romanelli, M. Perduca, D. Guardavaccaro, E. Crisafulli, D. Zipeto, L. Barile, M.T. Valenti
Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
2023 A. Celesia, M. Franzò, D. Di Liberto, M. Lauricella, D. Carlisi, A. D'Anneo, A. Notaro, M. Allegra, M. Giuliano, S. Emanuele
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
2023 C. Zichittella, M. Loria, A. Celesia, D. Di Liberto, C. Corrado, R. Alessandro, S. Emanuele, A. Conigliaro
Bortezomib potentiates the antitumor effect of tributyltin(IV) ferulate in colon cancer cells exacerbating ER stress and promoting apoptosis
2022 A. Celesia, T. Fiore, D. Di Liberto, M. Giuliano, C. Pellerito, S. Emanuele
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
2022 D. Carlisi, M. Lauricella, A. D'Anneo, A. De Blasio, A. Celesia, G. Pratelli, A. Notaro, G. Calvaruso, M. Giuliano, S. Emanuele
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
2022 A. Celesia, A. Notaro, M. Franzò, M. Lauricella, A. D'Anneo, D. Carlisi, M. Giuliano, S. Emanuele
Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells
2021 M. Giuliano, C. Pellerito, A. Celesia, T. Fiore, S. Emanuele
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
2021 S. Emanuele, A. Celesia, A. D'Anneo, M. Lauricella, D. Carlisi, A. De Blasio, M. Giuliano
Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects
2020 C. Pellerito, S. Emanuele, F. Ferrante, A. Celesia, M. Giuliano, T. Fiore
ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells
2020 A. Celesia, O. Morana, T. Fiore, C. Pellerito, A. D'Anneo, M. Lauricella, D. Carlisi, A. De Blasio, G. Calvaruso, M. Giuliano, S. Emanuele